Tagraxofusp in Patients With CD123+ or With BPDCN-IPh-like Acute Myeloid Leukemia
- First Posted Date
- 2020-04-13
- Last Posted Date
- 2025-01-30
- Target Recruit Count
- 25
- Registration Number
- NCT04342962
- Locations
- ๐ฎ๐น
Asst Degli Spedali Civili Di Brescia - Uo Ematologia, Brescia, Italy
๐ฎ๐นIrccs Aou San Martino - Genova - Uo Clinica Ematologica, Genova, Italy
๐ฎ๐นAou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia, Bologna, Italy
Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy
- Conditions
- Chronic Lymphocytic LeukemiaRelapse LeukemiaRefractory Leukemia
- Interventions
- First Posted Date
- 2020-02-25
- Last Posted Date
- 2025-01-17
- Target Recruit Count
- 321
- Registration Number
- NCT04282811
- Locations
- ๐ฎ๐น
Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto, Bari, Italy
๐ฎ๐นAou Arcispedale Sant'Anna - Cona (Fe) - Uoc Ematologia E Fisiopatologia Della Coagulazione, Cona, Ferrara, Italy
๐ฎ๐นAon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia, Alessandria, Italy
Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT)
- Conditions
- High-risk MDS
- Interventions
- First Posted Date
- 2019-12-03
- Last Posted Date
- 2025-04-29
- Target Recruit Count
- 274
- Registration Number
- NCT04184505
- Locations
- ๐ฎ๐น
Aso S. Croce E Carle - Sc Ematologia, Cuneo, Italy
๐ฎ๐นAou Ospedali Riuniti- Uoc Ematologia, Foggia, Italy
๐ฎ๐นAo Di Rilievo Nazionale Antonio Cardarelli - Napoli - Uoc Ematologia Con Trapianto Di Midollo, Napoli, Italy
AML Patients Bearing FLT3 Mutations Based on Peripheral Blast Clearance
- Conditions
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- Interventions
- First Posted Date
- 2019-11-22
- Last Posted Date
- 2022-03-02
- Target Recruit Count
- 172
- Registration Number
- NCT04174612
- Locations
- ๐ฎ๐น
Aou San Luigi Gonzaga - Orbassano - Scdu Ematologia Generale E Oncoematologia, Orbassano, Italy
๐ฎ๐นAulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia, Mestre, Italy
๐ฎ๐นAou Policlinico P. Giaccone - Palermo - Uo Ematologia, Palermo, Italy
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
- First Posted Date
- 2019-11-19
- Last Posted Date
- 2024-11-08
- Target Recruit Count
- 414
- Registration Number
- NCT04168502
- Locations
- ๐ฎ๐น
ASL Le/1 P.O. Vito Fazzi - UO Ematologia, Lecce, Italy
๐ฎ๐นAusl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia, Rimini, Italy
๐ฎ๐นAsui Di Udine - Presidio Ospedaliero "Santa Maria Della Misericordia" - Clinica Ematologica, Udine, Italy
The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir Alafenamide
- Conditions
- Large-B-cell Diffuse LymphomaChronic Lymphoid Leukemia
- Interventions
- First Posted Date
- 2019-01-15
- Last Posted Date
- 2025-02-27
- Target Recruit Count
- 5
- Registration Number
- NCT03804372
- Locations
- ๐ฎ๐น
Aon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia, Alessandria, Italy
๐ฎ๐นAou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona - Sod Clinica Ematologica, Ancona, Italy
๐ฎ๐นArea Vasta N. 5 Ascoli Piceno - S. Benedetto Del Tronto, Presidio Ospedaliero Av5 Osp. Gen. Prov.Le "C.G.Mazzoni" - Uoc Ematologia, Ascoli Piceno, Italy
Long-term Outcomes for Acute Myeloid Leukemia Patients
- Conditions
- Acute Myeloid Leukemia
- First Posted Date
- 2018-11-28
- Last Posted Date
- 2020-03-04
- Target Recruit Count
- 343
- Registration Number
- NCT03755856
- Locations
- ๐ง๐ช
UZ Gasthuisberg, Leuven, Belgium
๐ง๐ชCHR Citadelle-CHU, Liรจge, Belgium
๐ธ๐ฎUKC Ljubljana, Ljubljana, Slovenia
Long-term Safety Study of Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk Acute Promyelocytic Leukemia
- First Posted Date
- 2018-11-23
- Last Posted Date
- 2022-01-04
- Target Recruit Count
- 100
- Registration Number
- NCT03751917
- Locations
- ๐ฎ๐น
U.O.C. Oncoematologia - Istituto Oncologico Veneto Irccs, Presidio Ospedaliero S. Giacomo Apostolo, Castelfranco Veneto, Italy
๐ฎ๐นFondazione IRCCS Ca' Granda Osp. Maggiore Policlinico UOC Oncoematologia, Milano, Italy
๐ฎ๐นAzienda Ospedaliera "S.Gerardo", Monza, Italy
Asparaginase Activity Monitoring (AAM) in Adult Patients With Acute Lymphoblastic Leukemia (ALL)
- First Posted Date
- 2018-09-12
- Last Posted Date
- 2022-03-16
- Target Recruit Count
- 7
- Registration Number
- NCT03668392
- Locations
- ๐ฎ๐น
Asl Roma 2, Ospedale S. Eugenio- Ospedale S.Eugenio - Uoc Ematologia, Roma, Italy
๐ฎ๐นAou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona - Sod Clinica Ematologica, Ancona, Italy
๐ฎ๐นAso S. Croce E Carle - Cuneo - Sc Ematologia, Cuneo, Italy
Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia
- Conditions
- Acute Lymphoid Leukemia
- Interventions
- Drug: Inotuzumab Ozogamicin (IO)
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2022-01-04
- Target Recruit Count
- 76
- Registration Number
- NCT03610438
- Locations
- ๐ฎ๐น
I.R.S.T. Srl Irccs - Meldola - Sc Oncologia Medica, Meldola, Italy
๐ฎ๐นAsst Grande Ospedale Metropolitano Niguarda - Milano - Sc Ematologia, Milano, Italy
๐ฎ๐นIstituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia, Milano, Italy